These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16121256)

  • 1. Medium-chain acyl-CoA dehydrogenase deficiency in gene-targeted mice.
    Tolwani RJ; Hamm DA; Tian L; Sharer JD; Vockley J; Rinaldo P; Matern D; Schoeb TR; Wood PA
    PLoS Genet; 2005 Aug; 1(2):e23. PubMed ID: 16121256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living on the edge: substrate competition explains loss of robustness in mitochondrial fatty-acid oxidation disorders.
    van Eunen K; Volker-Touw CM; Gerding A; Bleeker A; Wolters JC; van Rijt WJ; Martines AM; Niezen-Koning KE; Heiner RM; Permentier H; Groen AK; Reijngoud DJ; Derks TG; Bakker BM
    BMC Biol; 2016 Dec; 14(1):107. PubMed ID: 27927213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the Mitochondrial Fatty Acid β-Oxidation Protein Medium-Chain Acyl-Coenzyme A Dehydrogenase Disrupts Oxidative Phosphorylation Protein Complex Stability and Function.
    Lim SC; Tajika M; Shimura M; Carey KT; Stroud DA; Murayama K; Ohtake A; McKenzie M
    Sci Rep; 2018 Jan; 8(1):153. PubMed ID: 29317722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heptanoic and medium branched-chain fatty acids as anaplerotic treatment for medium chain acyl-CoA dehydrogenase deficiency.
    Karunanidhi A; Basu S; Zhao XJ; D'Annibale O; Van't Land C; Vockley J; Mohsen AW
    Mol Genet Metab; 2023 Nov; 140(3):107689. PubMed ID: 37660571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical characterization of variant medium-chain acyl-CoA dehydrogenase in fibroblasts from patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Coates PM; Indo Y; Young D; Hale DE; Tanaka K
    Pediatr Res; 1992 Jan; 31(1):34-8. PubMed ID: 1594327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial fatty acid beta-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Tyni T; Paetau A; Strauss AW; Middleton B; Kivelä T
    Pediatr Res; 2004 Nov; 56(5):744-50. PubMed ID: 15347768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbed hepatic carbohydrate management during high metabolic demand in medium-chain acyl-CoA dehydrogenase (MCAD)-deficient mice.
    Herrema H; Derks TG; van Dijk TH; Bloks VW; Gerding A; Havinga R; Tietge UJ; Müller M; Smit GP; Kuipers F; Reijngoud DJ
    Hepatology; 2008 Jun; 47(6):1894-904. PubMed ID: 18459129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medium-chain acyl-CoA-dehydrogenase (MCAD) deficiency: French consensus for neonatal screening, diagnosis, and management].
    Feillet F; Ogier H; Cheillan D; Aquaviva C; Labarthe F; Baruteau J; Chabrol B; de Lonlay P; Valayanopoulos V; Garnotel R; Dobbelaere D; Briand G; Jeannesson E; Vassault A; Vianey-Saban C;
    Arch Pediatr; 2012 Feb; 19(2):184-93. PubMed ID: 22244319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cis-4-Decenoic and decanoic acids impair mitochondrial energy, redox and Ca(2+) homeostasis and induce mitochondrial permeability transition pore opening in rat brain and liver: Possible implications for the pathogenesis of MCAD deficiency.
    Amaral AU; Cecatto C; da Silva JC; Wajner A; Godoy KDS; Ribeiro RT; Wajner M
    Biochim Biophys Acta; 2016 Sep; 1857(9):1363-1372. PubMed ID: 27240720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in 2 patients with symptoms of Reye syndrome].
    Brus F; Smit GP; Knoester H; Reijngoud DJ
    Tijdschr Kindergeneeskd; 1988 Jun; 56(3):132-7. PubMed ID: 3046055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of energy metabolism in cerebral cortex of young rats by the medium-chain fatty acids accumulating in MCAD deficiency.
    Reis de Assis D; Maria Rde C; Borba Rosa R; Schuck PF; Ribeiro CA; da Costa Ferreira G; Dutra-Filho CS; Terezinha de Souza Wyse A; Duval Wannmacher CM; Santos Perry ML; Wajner M
    Brain Res; 2004 Dec; 1030(1):141-51. PubMed ID: 15567346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
    Schuler AM; Wood PA
    ILAR J; 2002; 43(2):57-65. PubMed ID: 11917157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium-chain acyl-CoA dehydrogenase deficiency: molecular aspects.
    Matsubara Y; Narisawa K; Tada K
    Eur J Pediatr; 1992 Mar; 151(3):154-9. PubMed ID: 1601002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the inborn errors of mitochondrial fatty acid beta-oxidation deficiency].
    Zhu JM; Yang Z
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 38(2):214-7. PubMed ID: 16617370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in The Netherlands: the importance of enzyme analysis to ascertain true MCAD deficiency.
    Derks TG; Boer TS; van Assen A; Bos T; Ruiter J; Waterham HR; Niezen-Koning KE; Wanders RJ; Rondeel JM; Loeber JG; Ten Kate LP; Smit GP; Reijngoud DJ
    J Inherit Metab Dis; 2008 Feb; 31(1):88-96. PubMed ID: 18188679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of dietary fatty acid chain-length on metabolic tolerance in mouse models of inherited defects in mitochondrial fatty acid beta-oxidation.
    Schuler AM; Gower BA; Matern D; Rinaldo P; Wood PA
    Mol Genet Metab; 2004 Dec; 83(4):322-9. PubMed ID: 15589119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex changes in the liver mitochondrial proteome of short chain acyl-CoA dehydrogenase deficient mice.
    Wang W; Mohsen AW; Uechi G; Schreiber E; Balasubramani M; Day B; Michael Barmada M; Vockley J
    Mol Genet Metab; 2014 May; 112(1):30-9. PubMed ID: 24685553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of heat stress and bezafibrate on mitochondrial beta-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay.
    Li H; Fukuda S; Hasegawa Y; Kobayashi H; Purevsuren J; Mushimoto Y; Yamaguchi S
    Brain Dev; 2010 May; 32(5):362-70. PubMed ID: 19589653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Messenger RNA rescues medium-chain acyl-CoA dehydrogenase deficiency in fibroblasts from patients and a murine model.
    Zhao XJ; Mohsen AW; Mihalik S; Solo K; Basu S; Aliu E; Shi H; Kochersberger C; Karunanidhi A; Van't Land C; Coughlan KA; Siddiqui S; Rice LM; Hillier S; Guadagnin E; DeAntonis C; Giangrande PH; Martini PGV; Vockley J
    Hum Mol Genet; 2023 Jul; 32(14):2347-2356. PubMed ID: 37162351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.